• 名称: EA.hy926(人脐静脉细胞融合A549细胞)
  • 货号: CBP60714
  • 浏览次数: 446
  • 已销售数量:0件
  • 评论信息
  • 购买数量:  购买数量不能低于最少订购数量!

购买 询价 收藏 QQ交流 好友推荐

CBP60714
I. General information 
Synonyms: EA.hy926
Background: The human umbilical vein cell line, EA.hy926, was established by fusing primary human umbilical vein cells with a thioguanine-resistant clone of A549 by exposure to polyethylene glycol (PEG). Hybrid clones were selected in HAT medium and screened for factor VIII-related antigen.
Species: Homo sapiens, human
Tissue: somatic cell hybrid
Morphology: endothelial
Growth Mode: adherent
DNA Profile: Amelogenin: X
CSF1PO: 10,11,12
D13S317: 11
D16S539: 11,12
D5S818: 11
D7S820: 8,9,10
THO1: 6,8,9.3
TPOX: 8,9
vWA: 14,17
Cobioer’s Cell Line Authentication Service
Culture Medium: DMEM+10%FBS
We strongly suggest to purchase the complete medium from Cobioer.
Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: Factor VIII-related antigen; Homo sapiens, expressed
Genes Expressed: Factor VIII-related antigen; Homo sapiens.
Tumor Formation: No, in immunosuppressed mice,Yes, in semisolid medium
Comments: Electron photomicrographs demonstrate cytoplasmic distribution of Weibel-Palade bodies and tissue-specific organelles, characteristics of differentiated endothelial cell functions such as angiogenesis, homeostasis/thrombosis, blood pressure and inflammation. Ref Ref
EA.hy926 cells have been maintained for more than 100 population doublings (PDLs).
For more information, please contact Cobioer (4008-750-250).

关键词: